AdaptHealth Corp. (NASDAQ:AHCO) Shares Sold by Sapience Investments LLC

Sapience Investments LLC lessened its holdings in shares of AdaptHealth Corp. (NASDAQ:AHCO) by 14.1% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 214,420 shares of the company’s stock after selling 35,280 shares during the quarter. Sapience Investments LLC’s holdings in AdaptHealth were worth $2,041,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. ProShare Advisors LLC raised its position in shares of AdaptHealth by 44.3% in the 4th quarter. ProShare Advisors LLC now owns 30,766 shares of the company’s stock worth $293,000 after buying an additional 9,450 shares during the period. Nuveen Asset Management LLC grew its stake in shares of AdaptHealth by 27.9% during the fourth quarter. Nuveen Asset Management LLC now owns 316,108 shares of the company’s stock valued at $3,009,000 after acquiring an additional 69,050 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in AdaptHealth by 3.6% in the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 57,931 shares of the company’s stock worth $552,000 after purchasing an additional 1,999 shares in the last quarter. Janus Henderson Group PLC grew its stake in AdaptHealth by 42.9% in the fourth quarter. Janus Henderson Group PLC now owns 38,298 shares of the company’s stock worth $364,000 after purchasing an additional 11,500 shares in the last quarter. Finally, Humankind Investments LLC lifted its holdings in AdaptHealth by 18.3% in the fourth quarter. Humankind Investments LLC now owns 17,979 shares of the company’s stock worth $171,000 after acquiring an additional 2,776 shares during the last quarter. Hedge funds and other institutional investors own 82.67% of the company’s stock.

Wall Street Analysts Forecast Growth

AHCO has been the topic of a number of recent research reports. Royal Bank of Canada cut their target price on shares of AdaptHealth from $14.00 to $13.00 and set an “outperform” rating on the stock in a report on Thursday, May 8th. Canaccord Genuity Group lifted their price target on shares of AdaptHealth from $13.00 to $14.00 and gave the stock a “buy” rating in a research report on Wednesday, February 26th. UBS Group decreased their price target on shares of AdaptHealth from $12.00 to $11.00 and set a “buy” rating for the company in a report on Thursday, February 13th. Robert W. Baird raised their price target on AdaptHealth from $14.00 to $16.00 and gave the stock an “outperform” rating in a research note on Thursday, February 27th. Finally, Truist Financial decreased their price objective on shares of AdaptHealth from $14.00 to $13.00 and set a “buy” rating for the company in a report on Monday, May 12th. Five equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, AdaptHealth presently has a consensus rating of “Buy” and a consensus price target of $13.40.

AdaptHealth Stock Performance

Shares of AdaptHealth stock opened at $9.02 on Friday. The firm has a 50 day simple moving average of $9.14 and a 200 day simple moving average of $9.68. The company has a debt-to-equity ratio of 1.34, a current ratio of 1.24 and a quick ratio of 1.00. AdaptHealth Corp. has a fifty-two week low of $7.11 and a fifty-two week high of $11.90. The firm has a market cap of $1.22 billion, a P/E ratio of -5.47, a P/E/G ratio of 1.08 and a beta of 1.64.

AdaptHealth Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.